Gelaspan vs standard fluids for sepsis with belly infection
Part of Infections clinical trials.
This trial tests whether a fluid called Gelaspan (a gelatin-based IV fluid) is better for treating sepsis patients who need emergency abdominal surgery than standard crystalloid fluids. It checks if you have a belly infection and high lactate levels, and you must not have serious heart, lung, or kidney problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have sepsis caused by an infection in your belly and need emergency surgery to control it
- Your blood lactate level is higher than 2 mmol/L (within the last 6 hours)
- You have not received colloid fluids (like gelatin) in the past 24 hours
- You do not have certain heart or lung conditions (like atrial fibrillation, congestive heart failure, or severe ARDS)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a type of diabetes medicine (SGLT2 inhibitors) can help adults with sepsis, a life-threatening response to infection. If you have new-onset sepsis and can take oral medicine, you may be eligible.
This trial tests two common fluids given in the emergency department for sepsis patients to see which is better. If you have sepsis (a severe infection) and need fluids, you may be able to join.
This Phase 2 study tests whether Pentaglobin®, a blood-product made from immune proteins, helps critically ill people with severe abdominal infection (peritonitis) after the infection source is surgically cleaned up. It targets patients with signs of strong inflammation and severe illness.
This study is testing a new way of measuring how much fluid leaks from your blood vessels during severe infection (septic shock). The goal is to help doctors decide how much fluid to give, which may improve recovery and prevent complications.
This trial tests a medicine called ulinastatin to see if it can help calm your body's overactive immune response during a serious belly infection. The goal is to reduce organ failure and help you recover faster.
This trial tests if a special fluid given through a vein can protect and repair the lining of your blood vessels during sepsis. Sepsis is a dangerous reaction to an infection that can damage organs. This study aims to see if this treatment helps patients in the intensive care unit (ICU) recover better.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.